Obagi Medical Products, Inc.

8-K

Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

04/26/13

8-K

Obagi Medical Products, Inc. and Valeant Pharmaceuticals, Inc. Agree on an Increased Offer Price of $24.00 Per Share in Cash

04/03/13

8-K

Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash

03/20/13

8-K

Reports Fourth Quarter and Year-End 2012 Financial Results

03/14/13

8-K

Confirms Receipt of Directors Nomination Notice From Voce Capital

12/10/12

8-K

####### ##### ####### #### ######### ####### ######## ###### ## ### ########### ############ #### ## ## #### ## #### ## ### #####

11/01/12

8-K

######## ########## ########## ######### ########## ## ########

10/29/12

Search in Documents

Key Exhibits

External Links

Financials Filter

Prospectuses and Registrations Filter

Ownership Filter

News Filter

Proxies Filter

Other Filter

Obagi Medical Products, Inc. Watch